Amgen Acquires BioVex for $1,000,000,000
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5263dbf4-981f-4829-9f03-b5774508aa17&Preview=1 - Date
1/25/2011 - Company Name
BioVex - Mailing Address
34 Commerce Way Woburn, MA 01801 - Company Description
The Company is developing a new class of potent biologics for the treatment
of cancer and prevention of infectious disease. - Website
http://www.biovex.com - Transaction Type
M&A - Transaction Amount
$1,000,000,000 - Transaction Round
- Proceeds Purposes
- M&A Terms
Under terms of the agreement, Amgen will pay up to $1 billion: $425 million in cash at closing and up to $575 million in additional payments upon the achievement of certain regulatory and sales milestones.
